Close Menu

I Want My DNA!

Writing in the New Scientist, Daniel MacArthur and Caroline Wright say that when it comes to DTC genetic testing, they "believe that regulation is needed, but are worried that it will focus too heavily on 'protecting' consumers from their own genomes." The authors note that once "lauded" as Time's invention of the year, personal genome scans have had a hard time "living up to that promise," and consequently their medical value has been limited. But, MacArthur and Wright say, not all DTC companies hold themselves to the same standards.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.